Re: KarXT

Posted by linkadge on November 11, 2021, at 17:54:29

In reply to Re: KarXT, posted by undopaminergic on November 11, 2021, at 3:25:01

I was just commenting on the link provided:
"Ulotaront, an agonist at the trace amine-associated receptor 1 (TAAR1) and 5-hydroxytryptamine type 1A (5-HT1A) receptors, received breakthrough therapy designation from the US Food and Drug Administration. The agonist does not bind to D2 or 5-HT2A."
Linkadge

Thread

NonD2AP Ulotaront Effective for Neg Sx in Sz iforgotmypassword 11/9/21
Re: NonD2AP Ulotaront Effective for Neg Sx in Sz Lamdage22 11/10/21
KarXT undopaminergic 11/10/21
Re: KarXT linkadge 11/10/21
Re: KarXT Lamdage22 11/10/21
Re: KarXT Lamdage22 11/11/21
Re: KarXT undopaminergic 11/11/21
Re: KarXT linkadge 11/11/21
Re: KarXT » undopaminergic linkadge 11/11/21
Re: KarXT » linkadge undopaminergic 11/11/21
Re: KarXT » linkadge SLS 11/12/21
Re: KarXT » undopaminergic SLS 11/12/21

Post a new follow-up

Notify the administrators

Start a new thread

poster:linkadge thread:1117414
URL: http://www.dr-bob.org/babble/20211102/msgs/1117437.html

	for
in